loadpatents
name:-0.97205805778503
name:-0.62205100059509
name:-0.063475847244263
Aerpio Therapeutics, Inc. Patent Filings

Aerpio Therapeutics, Inc.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Aerpio Therapeutics, Inc..The latest application filed is for "prolyl hydroxylase inhibitors".

Company Profile
15.60.72
  • Aerpio Therapeutics, Inc. - Cincinnati OH US
  • Aerpio Therapeutics, Inc. - Cincinati OH US
  • AERPIO THERAPEUTICS, INC - Cincinnati OH US
  • Aerpio Therapeutics, Inc. -
  • Aerpio Therapeutics Inc. - Cencinnati OH
  • Aerpio Therapeutics Inc. - Cincinatti OH US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Prolyl Hydroxylase Inhibitors
App 20220185778 - Gardner; Joseph H. ;   et al.
2022-06-16
Prolyl hydroxylase inhibitors
Grant 10,562,854 - Gardner , et al. Feb
2020-02-18
Treatment Of Ocular Disease
App 20200010565 - Peters; Kevin ;   et al.
2020-01-09
Methods Of Treating Diabetic Nephropathy Using Hptpb Inhibitors
App 20190262321 - PETERS; Kevin ;   et al.
2019-08-29
Compositions And Methods For Treating Ocular Diseases
App 20190231799 - Peters; Kevin ;   et al.
2019-08-01
Treatment of ocular disease
Grant 10,329,357 - Peters , et al.
2019-06-25
Methods For Treating Vascular Leak Syndrome And Cancer
App 20190177409 - Peters; Kevin ;   et al.
2019-06-13
Antibodies that target human protein tyrosine phosphatase-beta (HPTP-beta) and methods of use thereof to treat ocular conditions
Grant 10,253,094 - Peters , et al.
2019-04-09
Compounds, Compositions, And Methods For Preventing Metasasis Of Cancer Cells
App 20190076405 - Shalwitz; Robert ;   et al.
2019-03-14
HUMANIZED MONOCLONAL ANTIBODIES THAT TARGET VE-PTP (HPTP-Beta)
App 20190077863 - Peters; Kevin ;   et al.
2019-03-14
HUMANIZED MONOCLONAL ANTIBODIES THAT TARGET VE-PTP (HPTP-Beta)
App 20190077862 - Peters; Kevin ;   et al.
2019-03-14
Compositions and methods for treating ocular diseases
Grant 10,220,048 - Peters , et al.
2019-03-05
Prolyl Hydroxylase Inhibitors
App 20190055198 - Gardner; Joseph H. ;   et al.
2019-02-21
ANTIBODIES THAT BIND HUMAN PROTEIN TYROSINE PHOSPHATASE beta (HPTPbeta) AND USES THEREOF
App 20190023773 - Rotello; Rocco Jamie ;   et al.
2019-01-24
Hptp-beta Inhibitors
App 20180354937 - Janusz; John ;   et al.
2018-12-13
VE-PTP Extracellular Domain Antibodies Delivered by a Gene Therapy Vector
App 20180353614 - Peters; Kevin
2018-12-13
Methods for treating vascular leak syndrome and cancer
Grant 10,150,811 - Peters , et al. Dec
2018-12-11
Compositions, Formulations And Methods For Treating Ocular Diseases
App 20180251457 - Peters; Kevin ;   et al.
2018-09-06
Compositions, Formulations And Methods For Treating Ocular Diseases
App 20180237429 - Peters; Kevin ;   et al.
2018-08-23
Compositions, Formulations And Methods For Treating Ocular Diseases
App 20180237431 - Peters; Kevin ;   et al.
2018-08-23
Compositions, Formulations And Methods For Treating Ocular Diseases
App 20180237430 - Peters; Kevin ;   et al.
2018-08-23
Human Protein Tyrosine Phosphatase Inhibitors And Methods Of Use
App 20180221346 - Gray; Jeffrey Lyle ;   et al.
2018-08-09
HPTP-.beta. inhibitors
Grant 9,994,560 - Janusz , et al. June 12, 2
2018-06-12
Compounds, compositions, and methods for preventing metastasis of cancer cells
Grant 9,949,956 - Shalwitz , et al. April 24, 2
2018-04-24
Phosphatase Inhibitors For Treating Ocular Diseases
App 20180092883 - Peters; Kevin Gene ;   et al.
2018-04-05
Antibodies that bind human protein tyrosine phosphatase beta (HPTPbeta) and uses thereof
Grant 9,926,367 - Rotello , et al. March 27, 2
2018-03-27
Treatment Of Ocular Disease
App 20180044432 - Peters; Kevin ;   et al.
2018-02-15
Compositions And Methods For Treating Ocular Edema, Neovascularization And Related Diseases
App 20180037579 - Peters; Kevin Gene ;   et al.
2018-02-08
HUMANIZED MONOCLONAL ANTIBODIES THAT TARGET VE-PTP (HPTP-Beta)
App 20180022804 - Peters; Kevin ;   et al.
2018-01-25
Compositions, Formulations And Methods For Treating Ocular Diseases
App 20180022741 - Peters; Kevin ;   et al.
2018-01-25
Methods For Treating Vascular Leak Syndrome
App 20180016245 - Shalwitz; Robert ;   et al.
2018-01-18
Methods For Treating Vascular Leak Syndrome And Cancer
App 20180009890 - Peters; Kevin ;   et al.
2018-01-11
ANTIBODIES THAT BIND HUMAN PROTEIN TYROSINE PHOSPHATASE beta (HPTPbeta) AND USES THEREOF
App 20170349649 - Rotello; Rocco Jamie ;   et al.
2017-12-07
Compositions And Methods For Treating Ocular Diseases
App 20170319602 - Peters; Kevin ;   et al.
2017-11-09
Human protein tyrosine phosphatase inhibitors and methods of use
Grant RE46,592 - Gray , et al. October 31, 2
2017-10-31
Human protein tyrosine phosphatase inhibitors and methods of use
Grant 9,795,594 - Gray , et al. October 24, 2
2017-10-24
Prolyl Hydroxylase Inhibitors
App 20170298019 - Gardner; Joseph H. ;   et al.
2017-10-19
Methods Of Treating Intraocular Pressure With Activators Of Tie-2
App 20170079959 - Peters; Kevin Gene
2017-03-23
Prolyl hydroxylase inhibitors
Grant 9,540,326 - Gardner , et al. January 10, 2
2017-01-10
Combination of immunotherapies with activators of Tie-2
Grant 9,539,245 - Peters January 10, 2
2017-01-10
Human Protein Tyrosine Phosphatase Inhibitors And Methods Of Use
App 20160374996 - Gray; Jeffrey Lyle ;   et al.
2016-12-29
Compositions, formulations and methods for treating ocular diseases
Grant 9,440,963 - Peters , et al. September 13, 2
2016-09-13
Compositions, Formulations And Methods For Treating Ocular Diseases
App 20160220541 - Peters; Kevin ;   et al.
2016-08-04
Compositions, Formulations And Methods For Treating Ocular Diseases
App 20160220540 - Peters; Kevin ;   et al.
2016-08-04
Process for preparing N-benzyl-3-hydroxy-4-substituted-pyridin-2-(1H)-ones
Grant 9,388,135 - Alberico , et al. July 12, 2
2016-07-12
VE-PTP Extracellular Domain Antibodies Delivered by a Gene Therapy Vector
App 20160082129 - Peters; Kevin
2016-03-24
Human protein tyrosine phosphatase inhibitors and methods of use
Grant 9,284,285 - Gray , et al. March 15, 2
2016-03-15
Methods for increasing the stabilization of hypoxia inducible factor-.alpha.
Grant 9,278,930 - Shalwitz , et al. March 8, 2
2016-03-08
Combination of Immunotherapies with Activators of Tie-2
App 20160038467 - Peters; Kevin
2016-02-11
Compounds, Compositions, And Methods For Preventing Metasasis Of Cancer Cells
App 20160008327 - Shalwitz; Robert ;   et al.
2016-01-14
Compounds, compositions, and methods for preventing metastasis of cancer cells
Grant 9,174,950 - Shalwitz , et al. November 3, 2
2015-11-03
Hptp-beta Inhibitors
App 20150259335 - Janusz; John ;   et al.
2015-09-17
Human protein tyrosine phosphatase inhibitors and methods of use
Grant 9,126,958 - Gray , et al. September 8, 2
2015-09-08
Process For Preparing N-benzyl-3-hydroxy-4-substituted-pyridin-2-(1h)-ones
App 20150232425 - Alberico; Dino
2015-08-20
Treatment Of Ocular Diseases
App 20150232575 - Peters; Kevin ;   et al.
2015-08-20
Prolyl Hydroxylase Inhibitors
App 20150218098 - Gardner; Joseph H. ;   et al.
2015-08-06
Methods for treating vascular leak syndrome
Grant 9,096,555 - Shalwitz , et al. August 4, 2
2015-08-04
Human Protein Tyrosine Phosphatase Inhibitors And Methods Of Use
App 20150210656 - Gray; Jeffrey Lyle ;   et al.
2015-07-30
Methods For Increasing The Stabilization Of Hypoxia Inducible Factor-1 Alpha
App 20150157617 - Shalwitz; Robert ;   et al.
2015-06-11
Prolyl hydroxylase inhibitors
Grant 9,045,495 - Gardner , et al. June 2, 2
2015-06-02
Treatment of ocular disease
Grant 8,999,325 - Peters , et al. April 7, 2
2015-04-07
Methods for increasing the stabilization of hypoxia inducible factor-1 alpha
Grant 8,999,971 - Shalwitz , et al. April 7, 2
2015-04-07
Compositions And Methods For Treating Ocular Diseases
App 20150050277 - Peters; Kevin ;   et al.
2015-02-19
Human protein tyrosine phosphatase inhibitors and methods of use
Grant 8,946,232 - Gray , et al. February 3, 2
2015-02-03
Methods For Treating Vascular Leak Syndrome
App 20140378445 - Shalwitz; Robert ;   et al.
2014-12-25
Methods For Increasing The Stabilization Of Hypoxia Inducible Factor-1 Alpha
App 20140364419 - Shalwitz; Robert ;   et al.
2014-12-11
Human protein tyrosine phosphatase inhibitors and methods of use
Grant 8,895,563 - Gray , et al. November 25, 2
2014-11-25
Methods for increasing the stabilization of hypoxia inducible factor-1 alpha
Grant 8,883,774 - Shalwitz , et al. November 11, 2
2014-11-11
Compounds, compositions, and methods for preventing metastasis of cancer cells
Grant 8,883,832 - Shalwitz , et al. November 11, 2
2014-11-11
Human protein tyrosine phosphatase inhibitors and methods of use
Grant 8,846,685 - Gray , et al. September 30, 2
2014-09-30
Compositions And Methods For Treating Ocular Edema, Neovascularization And Related Diseases
App 20140288134 - Peters; Kevin Gene ;   et al.
2014-09-25
Compositions, formulations and methods for treating ocular diseases
App 20140275103 - Peters; Kevin ;   et al.
2014-09-18
Compounds, Compositions, And Methods For Preventing Metastasis Of Cancer Cells
App 20140249100 - Shalwitz; Robert Shalwitz ;   et al.
2014-09-04
Compounds, Compositions, And Methods For Preventing Metastasis Of Cancer Cells
App 20140242026 - Shalwitz; Robert ;   et al.
2014-08-28
Human Protein Tyrosine Phosphatase Inhibitors And Methods Of Use
App 20140221666 - Gray; Jeffrey Lyle ;   et al.
2014-08-07
Methods for increasing the stabilization of hypoxia inducible factor-1 alpha
Grant 8,778,412 - Shalwitz , et al. July 15, 2
2014-07-15
Methods For Treating Vascular Leak Syndrome
App 20140066458 - Shalwitz; Robert ;   et al.
2014-03-06
ANTIBODIES THAT BIND HUMAN PROTEIN TYROSINE PHOSPHATASE beta (HPTPbeta) AND USES TEHREOF
App 20140044707 - Rotello; Rocco Jamie ;   et al.
2014-02-13
Methods For Treating Vascular Leak Syndrome
App 20130331386 - Shalwitz; Robert ;   et al.
2013-12-12
Human Protein Tyrosine Phosphatase Inhibitors And Methods Of Use
App 20130324558 - Gray; Jeffrey Lyle ;   et al.
2013-12-05
Compounds, compositions, and methods for preventing metastasis of cancer cells
Grant 8,569,348 - Shalwitz , et al. October 29, 2
2013-10-29
Prolyl hydroxylase inhibitors
Grant 8,536,181 - Gardner , et al. September 17, 2
2013-09-17
Methods For Increasing The Stabilization Of Hypoxia Inducible Factor-1 Alpha
App 20130158010 - Shalwitz; Robert ;   et al.
2013-06-20
Prolyl Hydroxylase Inhibitors
App 20130158045 - Gardner; Joseph H. ;   et al.
2013-06-20
Treatment of Ocular Disease
App 20130095105 - Peters; Kevin ;   et al.
2013-04-18
Human Protein Tyrosine Phosphatase Inhibitors And Methods Of Use
App 20130096140 - Gray; Jeffrey Lyle ;   et al.
2013-04-18
Methods for Treating Vascular Leak Syndrome and Cancer
App 20130095065 - Peters; Kevin ;   et al.
2013-04-18
Human Protein Tyrosine Phosphatase Inhibitors And Methods Of Use
App 20130023543 - Gray; Jeffrey Lyle ;   et al.
2013-01-24
Human Protein Tyrosine Phosphatase Inhibitors And Methods Of Use
App 20130023542 - Gray; Jeffrey Lyle ;   et al.
2013-01-24
Human protein tyrosine phosphatase inhibitors and methods of use
Grant 8,338,615 - Gray , et al. December 25, 2
2012-12-25
Human protein tyrosine phosphatase inhibitors and method of use
Grant 8,329,916 - Amarasinghe , et al. December 11, 2
2012-12-11
Compositions and methods for treating colitis
Grant 8,309,537 - Gardner , et al. November 13, 2
2012-11-13
Human protein tyrosine phosphatase inhibitors and methods of use
Grant 8,258,311 - Gray , et al. September 4, 2
2012-09-04
Human protein tyrosine phosphatase inhibitors and methods of use
Grant 8,188,125 - Gray , et al. May 29, 2
2012-05-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed